AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE BESILATE + VALSARTAN
26 registrations across 5 African markets— 20 active
Markets with AMLODIPINE BESILATE + VALSARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMSTAN TABLETS (Each film coated tablet contains Amlodipine besilate/ Valsartan 10/160mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| AMSTAN TABLETS (Each film coated tablet contains Amlodipine besilate/ Valsartan 10/160mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| AMVA-DENK 5/80MG | 🇬🇭Ghana | — | active | Mar 2030 |
| AMVA-DENK 5/80MG | 🇬🇭Ghana | — | active | Mar 2030 |
| AMVA-DENK 10/160MG | 🇬🇭Ghana | — | active | Mar 2030 |
| AMVA-DENK 10/160MG | 🇬🇭Ghana | — | active | Mar 2030 |
| AMVA-DENK 5/160MG | 🇬🇭Ghana | — | active | Mar 2030 |
| AMVA-DENK 5/160MG | 🇬🇭Ghana | — | active | Mar 2030 |
| ZETAKARDOVAL 10/160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Oct 2029 |
| ZETAKARDOVAL 5/160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Oct 2029 |
| STARVAL-AM 10/160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | May 2029 |
| VALPLUS 5+ TABLET, COATED; ORAL | 🇿🇼Zimbabwe | KARLADE GLOBAL DMCC | active | Dec 2027 |
| VALMAC A 160/5 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LIMITED | active | Dec 2027 |
| AMVA_DENK_5/80MG 5/80MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| AMVA_DENK_5/160MG 5/160MG ORAL ORAL | 🇲🇼Malawi | — | expired | Mar 2025 |
| AMVA_DENK_10/160MG 10/160MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| STARVAL_AM_(10+160) 10/160MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| STARVAL_AM_(5+80) 5/80MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| STARVAL_AM_(5+160) 5/160MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| AMLODIPINE
BESILATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO | active | — |
| AMLODIPINE
BESILATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO | active | — |
| AMLODIPINE
BESILATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO | active | — |
| AMLODIPINE
BESILATE +
VALSARTAN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | DENK PHARMA GMBH & CO | active | — |
| STARVAL-AM comprimé / 10 mg / 160 mg | 🇸🇳Senegal | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | — |
| STARVAL AM comprimé / 10 mg / 160 mg | 🇸🇳Senegal | SUN PHARMA | active | — |
| STARVAL AM comprimé / 10 mg / 160 mg | 🇸🇳Senegal | SUN PHARMA | active | — |
AMLODIPINE BESILATE + VALSARTAN in Africa — Regulatory Overview
AMLODIPINE BESILATE + VALSARTAN is registered across 5 African markets with 26 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Zimbabwe, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 26 registrations, 20 (77%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.